Ono Pharmaceutical 관리
관리 기준 확인 3/4
Ono Pharmaceutical's CEO is Gyo Sagara, appointed in Sep 2008, has a tenure of 16.17 years. total yearly compensation is ¥190.00M, comprised of 41.1% salary and 58.9% bonuses, including company stock and options. directly owns 0.026% of the company’s shares, worth ¥234.98M. The average tenure of the management team and the board of directors is 1.8 years and 4.4 years respectively.
주요 정보
Gyo Sagara
최고 경영자
JP¥190.0m
총 보상
| CEO 급여 비율 | 41.1% |
| CEO 임기 | 16.2yrs |
| CEO 소유권 | 0.03% |
| 경영진 평균 재임 기간 | 1.8yrs |
| 이사회 평균 재임 기간 | 4.4yrs |
최근 관리 업데이트
Recent updates
Ono Pharmaceutical Co., Ltd. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year
Nov 03
We Think Ono Pharmaceutical (TSE:4528) Can Stay On Top Of Its Debt
Aug 25Ono Pharmaceutical Co., Ltd. (TSE:4528) First-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year
Aug 04There's No Escaping Ono Pharmaceutical Co., Ltd.'s (TSE:4528) Muted Earnings
Jun 24Ono Pharmaceutical (TSE:4528) Has Announced A Dividend Of ¥40.00
Mar 04Is There An Opportunity With Ono Pharmaceutical Co., Ltd.'s (TSE:4528) 42% Undervaluation?
Feb 27CEO 보상 분석
| 날짜 | 총 보상 | 급여 | 회사 수익 |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | JP¥95b |
| Jun 30 2024 | n/a | n/a | JP¥121b |
| Mar 31 2024 | JP¥190m | JP¥78m | JP¥128b |
| Dec 31 2023 | n/a | n/a | JP¥128b |
| Sep 30 2023 | n/a | n/a | JP¥125b |
| Jun 30 2023 | n/a | n/a | JP¥115b |
| Mar 31 2023 | JP¥228m | JP¥77m | JP¥113b |
보상 대 시장: Gyo's total compensation ($USD1.24M) is about average for companies of similar size in the JP market ($USD1.08M).
보상과 수익: Gyo's compensation has been consistent with company performance over the past year.
CEO
Gyo Sagara (66 yo)
16.2yrs
테뉴어
JP¥190,000,000
보상
Mr. Gyo Sagara has been the Chief Executive Officer at Ono Pharmaceutical Co., Ltd since April 01, 2024 and serves as it’s Director and served as its President since September 2008 until April 01, 2024 and...
리더십 팀
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| CEO & Chairman of the Board | 16.2yrs | JP¥190.00m | 0.026% ¥ 235.0m | |
| President | less than a year | 데이터 없음 | 0.0092% ¥ 84.2m | |
| Corp. Offcr. and Div. Dir. of Corp. Strategy & Planning | 1.3yrs | 데이터 없음 | 데이터 없음 | |
| Corporate Officer & Head of Risk and Compliance Management Department | 1.8yrs | 데이터 없음 | 데이터 없음 | |
| Managing Executive Officer | no data | 데이터 없음 | 데이터 없음 | |
| Corporate Officer & Head of Business Strategy Headquarters | 1.8yrs | 데이터 없음 | 데이터 없음 | |
| Ex. EO, Executive Dir. of Sus. Promotion Corp. Strategy & Planning and Representative Director | 1.8yrs | 데이터 없음 | 0.0060% ¥ 54.8m | |
| Corporate Officer & Deputy Executive Director | no data | 데이터 없음 | 데이터 없음 | |
| Corporate Officer & Head of Medical Affairs | no data | 데이터 없음 | 데이터 없음 | |
| Managing Executive Officer & CMC / Production Division Chief | no data | 데이터 없음 | 데이터 없음 | |
| Head of Development Div. | no data | 데이터 없음 | 데이터 없음 |
1.8yrs
평균 재임 기간
60yo
평균 연령
경험이 풍부한 관리: 4528's management team is not considered experienced ( 1.8 years average tenure), which suggests a new team.
이사회 구성원
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| CEO & Chairman of the Board | 18.4yrs | JP¥190.00m | 0.026% ¥ 235.0m | |
| President | 4.4yrs | 데이터 없음 | 0.0092% ¥ 84.2m | |
| Ex. EO, Executive Dir. of Sus. Promotion Corp. Strategy & Planning and Representative Director | 4.4yrs | 데이터 없음 | 0.0060% ¥ 54.8m | |
| Independent Outside Director | 3.4yrs | 데이터 없음 | 데이터 없음 | |
| Outside Audit & Supervisory Board Member | 4.4yrs | 데이터 없음 | 데이터 없음 | |
| Outside Audit & Supervisory Board Member | 8.4yrs | 데이터 없음 | 데이터 없음 | |
| Audit & Supervisory Board Member | less than a year | 데이터 없음 | 0.0032% ¥ 29.3m | |
| Independent Outside Director | 6.4yrs | 데이터 없음 | 데이터 없음 | |
| Independent Outside Director | 4.4yrs | 데이터 없음 | 데이터 없음 | |
| Chairman of Audit Supervisory Board | 3.4yrs | 데이터 없음 | 0.00043% ¥ 4.0m |
4.4yrs
평균 재임 기간
60yo
평균 연령
경험이 풍부한 이사회: 4528's board of directors are considered experienced (4.4 years average tenure).